Aridis Pharmaceuticals In... (ARDS)
OTC: ARDS
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 01, 2025, 9:51 AM
Aridis Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 417K | 19.65M | n/a | n/a | n/a | 292K | n/a | 570K | 98K | 33K | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 417K | 19.65M | n/a | n/a | n/a | 292K | n/a | 570K | 98K | 33K | n/a |
Operating Income | -869K | 13.67M | -6.26M | -7.42M | -7.41M | -7.74M | -7.42M | -9.97M | -21.03M | -6.23M | -6.9M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 94K | -2K | 1K | n/a | 1K |
Pretax Income | -83K | 12.14M | -6.82M | -6.39M | -8.24M | -7.98M | -7.77M | -10.23M | -21M | -5.49M | -6.89M |
Net Income | -83K | 12.14M | -6.82M | -6.39M | -9.07M | -8.22M | -8.11M | -10.23M | -21M | -5.49M | -6.89M |
Selling & General & Admin | 1.11M | 1.31M | 1.81M | 1.63M | 1.69M | 1.68M | 2.16M | 1.95M | 1.7M | 1.69M | 1.94M |
Research & Development | 175K | 4.67M | 5.53M | 7.01M | 6.12M | 6.35M | 6.45M | 8.59M | 19.84M | 4.57M | 4.96M |
Other Expenses | -417K | -1.53M | -1.08M | -1.21M | -399K | -250K | -1.19M | -11K | 23K | 22K | 7K |
Operating Expenses | 869K | 5.98M | 6.26M | 7.42M | 7.41M | 8.03M | 7.42M | 9.97M | 21.12M | 6.27M | 6.9M |
Interest Expense | n/a | 3K | n/a | n/a | n/a | 8K | 342K | 245K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 869K | 5.98M | 6.26M | 7.42M | 7.41M | 8.03M | 7.42M | 9.97M | 21.12M | 6.27M | 6.9M |
Income Tax Expense | n/a | -3K | n/a | n/a | 827K | 242K | 342K | 245K | -1K | -722K | -1K |
Shares Outstanding (Basic) | 37.43M | 36.08M | 30.41M | 18.24M | 17.7M | 17.7M | 17.7M | 14.5M | 12.45M | 11.23M | 10.23M |
Shares Outstanding (Diluted) | 37.43M | 36.57M | 30.41M | 18.24M | 17.7M | 17.7M | 17.7M | 14.5M | 12.45M | 11.23M | 10.23M |
EPS (Basic) | -0.00 | 0.34 | -0.22 | -0.35 | -0.51 | -0.46 | -0.46 | -0.71 | -1.69 | -0.49 | -0.67 |
EPS (Diluted) | -0.00 | 0.33 | -0.22 | -0.35 | -0.51 | -0.46 | -0.46 | -0.71 | -1.69 | -0.49 | -0.67 |
EBITDA | -810K | 13.73M | -6.18M | -7.32M | -7.29M | -7.61M | -7.29M | -8.83M | -20.93M | -6.14M | -6.81M |
EBIT | -869K | 13.67M | -6.26M | -7.42M | -7.41M | -7.74M | -7.42M | -8.55M | -21.03M | -6.23M | -6.9M |
Depreciation & Amortization | 59K | 63K | 87K | 100K | 125K | 131K | 131K | 157K | 94K | 93K | 91K |